Document is current
Any future updates will be listed below
-
Authors
Kobayashi, Shin https://orcid.org/0000-0001-9321-8452
Takahashi, Shinichiro
Takahashi, Naoki
Masuishi, Toshiki
Shoji, Hirokazu
Shinozaki, Eiji
Yamaguchi, Tatsuro
Kojima, Motohiro
Gotohda, Naoto
Nomura, Shogo
Yoshino, Takayuki
Taniguchi, Hiroya
-
Funding
Funding for this research was provided by:
National Cancer Center (National Cancer Center Research Development Fund ()
- License Information
-
More Information
Article History
Received: 13 February 2020
Accepted: 19 April 2020
First Online: 13 July 2020
Disclosure
: Hiroya Taniguchi received honoraria from Takeda, Chugai, and Taiho pharmaceutical companies. Takayuki Yoshino received research funding from Novartis Pharma K.K., MSD.K.K., Sumitomo Dainippon Pharma Co., Ltd., CHUGAI PHARMACEUTICAL CO., LTD., Sanofi K.K., DAIICHI SANKYO COMPANY, LIMITED, PAREXEL International Inc., ONO PHARMACEUTICAL CO., LTD. and GlaxoSmithKline K.K. Toshiki Masuishi received honoraria from Takeda, Chugai, Merck Serono, Taiho, Bayer, Lilly Japan, Yakult Honsha, and Sanofi pharmaceutical companies, and research funding from MSD, Daiichi Sankyo, and Ono pharmaceutical companies.
